<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24567" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Yellow Nail Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cheslock</surname>
            <given-names>Megan</given-names>
          </name>
          <aff>Naples Community Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Harrington</surname>
            <given-names>Douglas W.</given-names>
          </name>
          <aff>Mayo Clinic</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Megan Cheslock declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Douglas Harrington declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24567.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Yellow nail syndrome (YNS) is a rare disorder characterized by slow-growing, yellow, thickened nails, lymphedema, and respiratory tract involvement. Pulmonary symptoms, such as pleural effusions or bronchiectasis, often accompany the nail abnormalities, while lymphedema may involve the extremities. Though YNS primarily affects adults aged 50 and older, it has also been documented in children. The exact cause remains unknown, and the syndrome is often misdiagnosed, leading to unnecessary tests and delayed treatment. Early identification of the triad of symptoms is crucial for effective management.</p>
        <p>This educational activity provides healthcare professionals with the knowledge to diagnose and manage yellow nail syndrome accurately. Participants learn to differentiate YNS from other conditions and apply appropriate treatment strategies, including managing respiratory complications and lymphedema. The course also emphasizes the importance of interprofessional collaboration, where dermatologists, pulmonologists, and other specialists work together to enhance patient outcomes and reduce the morbidity associated with the syndrome.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate yellow nail syndrome from other conditions that may present with similar symptoms, such as psoriasis or fungal infections.</p></list-item><list-item><p>Screen patients with yellowing nails for associated conditions, including pleural effusion and lymphedema, to ensure a comprehensive evaluation.</p></list-item><list-item><p>Implement evidence-based management strategies for yellow nail syndrome, focusing on symptom relief and addressing associated conditions.</p></list-item><list-item><p>Determine&#x000a0;interprofessional team strategies for improving care coordination and communication to advance yellow nail syndrome and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24567&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24567">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24567.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Yellow nail syndrome (YNS) is a rare condition defined by&#x000a0;the presence of&#x000a0;2 of the following 3 symptoms:</p>
        <list list-type="order">
          <list-item>
            <p>Slow-growing, hard, yellow, and dystrophic nails</p>
          </list-item>
          <list-item>
            <p>Lymphedema</p>
          </list-item>
          <list-item>
            <p>Respiratory tract disease&#x000a0;<xref ref-type="bibr" rid="article-24567.r1">[1]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>The earliest case of YNS&#x000a0;was reported by Heller&#x000a0;in 1927.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref>&#x000a0;However,&#x000a0;in 1947, Samman and&#x000a0; White&#x000a0;published&#x000a0;the first case series of YNS in patients with nail discoloration&#x000a0;and&#x000a0;lymphedema.<xref ref-type="bibr" rid="article-24567.r3">[3]</xref>&#x000a0;Pulmonary disease, specifically pleural effusion, was added to the diagnostic criteria by&#x000a0;Emerson&#x000a0;in 1966.<xref ref-type="bibr" rid="article-24567.r4">[4]</xref>&#x000a0;The syndrome generally affects adults aged 50 and older. However, case reports of YNS occur in children&#x000a0;and even newborns.<xref ref-type="bibr" rid="article-24567.r5">[5]</xref>&#x000a0;Anatomically, YNS affects the fingernails, toenails, the respiratory tract, and gravity-dependent areas that can accumulate fluid (typically lower extremities). These signs and symptoms are believed to be due to dysfunction in lymphatic&#x000a0;drainage.<xref ref-type="bibr" rid="article-24567.r3">[3]</xref><xref ref-type="bibr" rid="article-24567.r4">[4]</xref><xref ref-type="bibr" rid="article-24567.r6">[6]</xref><xref ref-type="bibr" rid="article-24567.r7">[7]</xref></p>
        <p>
<bold>Nails</bold>
</p>
        <p>As the name suggests, xanthonychia (yellow nail coloration) is a common feature of YNS; however, yellow nails are not required if&#x000a0;2 of the other clinical signs are present. Discoloration varies from pale yellow to dark green; nails can be opaque or translucent.<xref ref-type="bibr" rid="article-24567.r8">[8]</xref>&#x000a0;The&#x000a0;manifestations are commonly misdiagnosed as onychomycosis (discoloration due to fungal infection), as the nails may become thickened, hard, and curved.<xref ref-type="bibr" rid="article-24567.r9">[9]</xref>&#x000a0;A&#x000a0;quick inspection of fingernails and toenails can help expand the differential for a patient with&#x000a0;other vague complaints without additional expense.</p>
        <p>
<bold>Respiratory Tract</bold>
</p>
        <p>The respiratory tract is involved in more than half of patients with YNS.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref><xref ref-type="bibr" rid="article-24567.r7">[7]</xref>&#x000a0;The most common manifestation is a chronic cough, followed by pleural effusion.<xref ref-type="bibr" rid="article-24567.r7">[7]</xref>&#x000a0;In one of the largest reviews of patients with YNS, Vald&#x000e9;s et al found nearly all effusions exudative with&#x000a0;a lymphocytic predominance. Of the 66 subjects,&#x000a0;approximately 70% of effusions were bilateral.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref><xref ref-type="bibr" rid="article-24567.r10">[10]</xref>&#x000a0;Other pulmonary manifestations include bronchiectasis, recurrent pneumonia, sinusitis, and pulmonary fibrosis.<xref ref-type="bibr" rid="article-24567.r11">[11]</xref>&#x000a0;Pulmonary function testing in YNS is typically unremarkable, and biopsies do not usually contribute to the diagnosis.<xref ref-type="bibr" rid="article-24567.r10">[10]</xref></p>
        <p>
<bold>Lymphedema</bold>
</p>
        <p>Lymphedema typically manifests in the bilateral lower extremities and does not differ in appearance from primary lymphedema.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref>&#x000a0;Lymphedema occurs in 30% to 80% of patients.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref><xref ref-type="bibr" rid="article-24567.r7">[7]</xref><xref ref-type="bibr" rid="article-24567.r12">[12]</xref>&#x000a0;Dynamic lymphatic imaging (lymphoscintigraphy) does differ&#x000a0;between patients with edema related to YNS and those with primary lymphedema.<xref ref-type="bibr" rid="article-24567.r13">[13]</xref>&#x000a0;Edema can be pitting and can be easily confused with fluid accumulation, often seen in patients with decompensated congestive heart failure. This can be especially deceiving if patients present with concurrent pleural effusions. As in primary lymphedema, treatments often involve massage,&#x000a0;compression dressing, exercises, and, less commonly, surgical interventions.<xref ref-type="bibr" rid="article-24567.r14">[14]</xref></p>
        <p>
<bold>Natural History&#x000a0;</bold>
</p>
        <p>The diagnosis of YNS can be difficult because patients rarely present concurrently with all&#x000a0;3 clinical criteria. Lymphedema is the initial symptom in approximately one-third of YNS&#x000a0;diagnoses.<xref ref-type="bibr" rid="article-24567.r12">[12]</xref>&#x000a0;The prognosis and disease course depend on the individual's symptoms and the timing of diagnosis. In some mild cases, the symptoms of YNS can be resolved without intervention. Unfortunately, many symptoms recur&#x000a0;despite treatment and require continuous care. YNS can negatively affect one's quality of life, including cosmesis and worsening functional status. Recurring soft tissue infections (eg, cellulitis from severe lymphedema), pulmonary infections (pneumonia/empyema), and pulmonary effusions can lead to complications such as antibiotic resistance, pulmonary scarring, and protein loss.<xref ref-type="bibr" rid="article-24567.r15">[15]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-24567.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The specific cause of yellow nail syndrome (YNS) is unclear. The most widely accepted&#x000a0;explanation for the signs and symptoms associated with YNS&#x000a0;is a dysfunction of the lymphatic system, specifically lymphatic drainage.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref><xref ref-type="bibr" rid="article-24567.r4">[4]</xref><xref ref-type="bibr" rid="article-24567.r16">[16]</xref>&#x000a0;Imaging lymphatic system and lymph transport&#x000a0;using lymphoscintigraphy&#x000a0;is abnormal in&#x000a0;YNS.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref>&#x000a0;Interestingly, study results have shown a difference in lymphatic drainage in patients with YNS compared to those with primary lymphedema.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref><xref ref-type="bibr" rid="article-24567.r13">[13]</xref>&#x000a0;Another proposed etiology of YNS is exposure to&#x000a0;titanium,&#x000a0;specifically titanium dioxide (used in various products such as dental and joint implants, surgical staples, and cosmetics).<xref ref-type="bibr" rid="article-24567.r17">[17]</xref><xref ref-type="bibr" rid="article-24567.r18">[18]</xref>&#x000a0;</p>
        <p>When compared&#x000a0;with healthy controls, nail clippings from patients with YNS contained&#x000a0;elevated levels of&#x000a0;titanium.<xref ref-type="bibr" rid="article-24567.r17">[17]</xref><xref ref-type="bibr" rid="article-24567.r19">[19]</xref>&#x000a0;Furthermore, case reports exist in which&#x000a0;the removal of titanium-containing implants led to the resolution of YNS.<xref ref-type="bibr" rid="article-24567.r19">[19]</xref>&#x000a0;Rare cases have also been reported after mitral valve replacement.<xref ref-type="bibr" rid="article-24567.r20">[20]</xref>&#x000a0;Although&#x000a0;cases of familial and congenital YNS have been reported, in the majority of cases, YNS is an acquired disorder of the lymphatic system that presents later in life.<xref ref-type="bibr" rid="article-24567.r21">[21]</xref>&#x000a0;YNS has also been associated with certain malignancies, autoimmune diseases, and immunodeficiency disorders.<xref ref-type="bibr" rid="article-24567.r22">[22]</xref><xref ref-type="bibr" rid="article-24567.r23">[23]</xref><xref ref-type="bibr" rid="article-24567.r24">[24]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-24567.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The exact prevalence of YNS is unknown, and most of the literature on YNS involves case reports. The estimated prevalence is less than 1&#x000a0;in 1,000,000.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref>&#x000a0;This condition occurs more commonly in those aged 50 and older, affecting men and women equally.<xref ref-type="bibr" rid="article-24567.r7">[7]</xref><xref ref-type="bibr" rid="article-24567.r12">[12]</xref>&#x000a0;Congenital and pediatric cases are extremely rare.<xref ref-type="bibr" rid="article-24567.r5">[5]</xref><xref ref-type="bibr" rid="article-24567.r25">[25]</xref><xref ref-type="bibr" rid="article-24567.r26">[26]</xref>&#x000a0;If YNS is suspected in a young patient, special care should be taken&#x000a0;to rule out other&#x000a0;related lymphatic system disorders.</p>
      </sec>
      <sec id="article-24567.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>As the underlying cause of YNS is unknown, the pathophysiology is also unclear.&#x000a0;The most widely accepted&#x000a0;cause of YNS is thought to be related to&#x000a0;abnormalities&#x000a0;in lymphatic flow. Based on their investigations involving quantitative lymphoscintigraphy, Bull et al argued that unlike primary lymphedema, which is due to permanent structural lymphatic abnormalities, the&#x000a0;abnormalities observed in YNS appear to be functional and potentially reversible.<xref ref-type="bibr" rid="article-24567.r13">[13]</xref>&#x000a0;They propose that perhaps an inflammatory component that leads to altered capillary permeability, fluid shifts, and alterations in blood flow is likely the cause of&#x000a0;the edema in YNS.</p>
      </sec>
      <sec id="article-24567.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathological examination of nails&#x000a0;is important to rule out other common causes of yellow nails, such as onychomycosis. The appearance of nails in YNS is varied; changes include a thickened nail plate with exaggerated curvature, xanthonychia (yellow discoloration), scleronychia (hardening of the nail), onycholysis (separation of the nail plate and nail bed), and slow growth.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref><xref ref-type="bibr" rid="article-24567.r9">[9]</xref>&#x000a0;Thoracentesis and fluid examination typically reveal a serous exudative effusion when a pleural effusion is present.<xref ref-type="bibr" rid="article-24567.r10">[10]</xref>&#x000a0;In their case series study,&#x000a0;Vald&#x000e9;s&#x000a0;et al found that pleural fluid samples most often had lymphocytic predominance with low numbers of nucleated cells with a pleural fluid protein greater than 3&#x02009;g/dL.</p>
      </sec>
      <sec id="article-24567.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>History</bold>
</p>
        <p>A thorough history&#x000a0;is crucial to&#x000a0;diagnosing YNS. Open-ended questioning and a&#x000a0;detailed review of the pulmonary, vascular, and integumentary systems&#x000a0;can reveal&#x000a0;clues that may lead to the diagnosis of this rare syndrome.&#x000a0;The pulmonary findings in YNS vary widely; therefore, asking about persistent cough, congestion, and recurrent respiratory infections is important. A review of past medical history, social history (ie,&#x000a0;smoking status, respiratory irritant exposure), and previous chest imaging are essential. Symptoms can be mild, intermittent, and may not present concurrently.&#x000a0;</p>
        <p>
<bold>Physical Exam </bold>
</p>
        <p>Special attention should be paid to analyzing fingernails and toenails and removing polish if necessary. Nail findings&#x000a0;can be subtle; the discoloration can range in intensity from pale yellow to green.<xref ref-type="bibr" rid="article-24567.r8">[8]</xref>&#x000a0;Nails can be thickened or irregular and are often slow-growing and brittle.<xref ref-type="bibr" rid="article-24567.r9">[9]</xref>&#x000a0;The physical appearance of lymphedema in YNS is no different than what is seen in primary lymphedema. Based on case reports, lymphedema is the&#x000a0;initial symptom of YNS in approximately one-third of patients, and it is present in approximately 30% to 80%&#x000a0;of those diagnosed with the syndrome.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref><xref ref-type="bibr" rid="article-24567.r7">[7]</xref><xref ref-type="bibr" rid="article-24567.r12">[12]</xref>&#x000a0;Lymphedema is&#x000a0;most commonly found in the bilateral lower extremities and other gravity-dependent areas.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref>&#x000a0;Although clinical signs have poor diagnostic reliability, the Kaposi-Stemmer sign (inability to pinch and lift the skin at the dorsum of the base of the second toe)&#x000a0;is&#x000a0;the most useful.<xref ref-type="bibr" rid="article-24567.r27">[27]</xref>&#x000a0;Pitting is present early in the course of lymphedema; however, as it progresses and the skin thickens and hardens, pitting is less clear.<xref ref-type="bibr" rid="article-24567.r28">[28]</xref>&#x000a0;Edema associated with venous obstruction and lymphedema is often difficult to distinguish.&#x000a0;</p>
        <p>Respiratory tract manifestations&#x000a0;in YNS occur in 60% to 70% of patients, the most common of which is a chronic cough.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref><xref ref-type="bibr" rid="article-24567.r7">[7]</xref>&#x000a0;A careful history&#x000a0;can help direct a thorough physical exam. Pleural effusions can be detected through auscultation and percussion. Facial fullness, tenderness to palpation of sinuses, and edematous nasal turbinates can be signs of chronic sinusitis.<xref ref-type="bibr" rid="article-24567.r29">[29]</xref>&#x000a0;Other pulmonary manifestations can occur, such as&#x000a0;bronchiectasis&#x000a0;and fibrosis.</p>
      </sec>
      <sec id="article-24567.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of YNS is clinical, and no specific test is required or diagnostic. More commonly encountered diagnoses, such as heart failure, primary lymphedema, and onychomycosis, should be ruled out. This can be done by thoroughly investigating the patient's history and physical exam or by requiring additional tests. Potential testing may include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Echocardiography to rule out heart failure</p>
          </list-item>
          <list-item>
            <p>Chest radiography&#x000a0;to identify&#x000a0;pneumonia or&#x000a0;other pulmonary&#x000a0;pathology</p>
          </list-item>
          <list-item>
            <p>Computed tomography of the sinuses to assess for chronic sinusitis</p>
          </list-item>
          <list-item>
            <p>Testing for infection,&#x000a0;such as sputum analysis or&#x000a0;complete blood count</p>
          </list-item>
          <list-item>
            <p>Analysis of nail scrapings or clippings to rule out onychomycosis</p>
          </list-item>
          <list-item>
            <p>Thoracentesis with an evaluation of pleural fluid</p>
          </list-item>
          <list-item>
            <p>Lymphoscintigraphy to identify lymphatic insufficiency</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24567.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of yellow nail syndrome focuses on treating symptoms. If thought to be a paraneoplastic syndrome, the treatment of underlying cancer may lead to resolution.<xref ref-type="bibr" rid="article-24567.r30">[30]</xref>&#x000a0;Sometimes, YNS can be resolved without intervention.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref></p>
        <p>
<bold>Pulmonary Symptoms</bold>
</p>
        <p>Pleural effusions are usually treated with thoracentesis. Octreotide is effective in&#x000a0;some cases of chylous effusions associated with YNS.<xref ref-type="bibr" rid="article-24567.r31">[31]</xref>&#x000a0;Unfortunately, pleural effusions tend to recur and may require definitive interventions, including decortication, pleurodesis, or thoracic duct embolization.<xref ref-type="bibr" rid="article-24567.r10">[10]</xref>&#x000a0;Antibiotic prophylaxis can be offered if the patient has recurrent infections or advanced bronchiectasis.<xref ref-type="bibr" rid="article-24567.r11">[11]</xref>&#x000a0;Pneumococcal and seasonal influenza vaccines are recommended.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref>&#x000a0;</p>
        <p>
<bold>Dystrophic and Discolored Nails</bold>
</p>
        <p>Nail disease in YNS can resolve spontaneously. Evidence for using oral vitamin E to treat nail discoloration has&#x000a0;mixed success.<xref ref-type="bibr" rid="article-24567.r32">[32]</xref>&#x000a0;Antifungals, combined with vitamin E, have been used despite&#x000a0;the&#x000a0;absence of fungal infection.<xref ref-type="bibr" rid="article-24567.r33">[33]</xref>&#x000a0;Other proposed treatments, such as oral zinc, clarithromycin, and corticosteroid injections, have poor evidence to support their use.<xref ref-type="bibr" rid="article-24567.r34">[34]</xref><xref ref-type="bibr" rid="article-24567.r35">[35]</xref><xref ref-type="bibr" rid="article-24567.r36">[36]</xref></p>
        <p>
<bold>Lymphedema</bold>
</p>
        <p>Lymphedema observed in YNS is treated&#x000a0;with the same interventions used in primary lymphedema. Generally, nonsurgical interventions include compression garments, bandaging, skin care, manual lymph drainage, and exercises.<xref ref-type="bibr" rid="article-24567.r37">[37]</xref></p>
      </sec>
      <sec id="article-24567.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Because YNS&#x000a0;involves multiple symptoms from&#x000a0;various organ systems, the differential diagnosis is broad. The pulmonary manifestations of YNS, such as pleural plaques and pleural thickening, have characteristics similar to those of asbestos-related lung disease.<xref ref-type="bibr" rid="article-24567.r38">[38]</xref>&#x000a0;Heart failure, which is far more prevalent than YNS, is commonly associated with lower extremity edema and pulmonary effusions in its decompensated state.<xref ref-type="bibr" rid="article-24567.r39">[39]</xref>&#x000a0;Edema due to vascular congestion is usually improved with&#x000a0;diuresis,&#x000a0;which is not the case with lymphedema. Systemic illnesses, such as connective tissue disease, autoimmune conditions, various malignancies, endocrine abnormalities, and immunodeficiency states,&#x000a0;can be associated with yellow nails.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref>&#x000a0;Onychomycosis must also be considered in patients with yellowed dystrophic nails.<xref ref-type="bibr" rid="article-24567.r40">[40]</xref></p>
      </sec>
      <sec id="article-24567.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis in YNS depends on the patient's symptoms and co-existing illnesses. Symptoms range from mild (poor nail cosmesis and chronic cough) to severe (marked and recurring edema, persistent pulmonary infections). There is no cure for YNS; treatment aims to improve symptoms.</p>
      </sec>
      <sec id="article-24567.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Because YNS involves multiple organ systems,&#x000a0;complications depend on which specific symptoms the patient exhibits. Dystrophic and discolored nails can cause psychological distress&#x000a0;from embarrassment, and onycholysis can be painful.<xref ref-type="bibr" rid="article-24567.r2">[2]</xref>&#x000a0;There are potentially life-threatening complications related to&#x000a0;the pulmonary and lymphatic manifestations observed in YNS.</p>
        <p>
<bold>Pulmonary</bold>
</p>
        <p>Large and persistent pleural effusions are uncomfortable and can cause a significant decline in&#x000a0;functional status. Effusions are associated with other potentially fatal complications, such as infection and respiratory distress.<xref ref-type="bibr" rid="article-24567.r10">[10]</xref>&#x000a0;Often, serial thoracenteses are required and carry the risk of infection, bleeding, pneumothorax, and significant discomfort.<xref ref-type="bibr" rid="article-24567.r41">[41]</xref>&#x000a0;Frequent draining of pleural effusions (which are&#x000a0;high in protein) can lead to hypoalbuminemia, which further exacerbates edema and the recurrence of effusions.<xref ref-type="bibr" rid="article-24567.r42">[42]</xref>&#x000a0;Frequent prescribing of antimicrobials due to recurring respiratory infections can lead to antibiotic resistance.</p>
        <p>
<bold>Lymphatic</bold>
</p>
        <p>Significant edema usually affects the bilateral lower extremities, leading to difficulty with ambulation and deconditioning. Furthermore, longstanding lymphedema leads to changes in skin texture and color, which can be esthetically&#x000a0;unappealing and can lead to cellulitis and other infections.<xref ref-type="bibr" rid="article-24567.r43">[43]</xref><xref ref-type="bibr" rid="article-24567.r44">[44]</xref>&#x000a0;Additional areas for fluid&#x000a0;accumulation include the peritoneal space, which may require paracentesis, genitalia, leading to tissue breakdown and discomfort, and the periorbital area, which can cause difficulty with vision.<xref ref-type="bibr" rid="article-24567.r45">[45]</xref></p>
      </sec>
      <sec id="article-24567.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Yellow nail syndrome is an extremely rare diagnosis that can go undiagnosed or misdiagnosed for years before other more common conditions are ruled out. If standard therapy is not successful, the interprofessional team and caretakers must advocate for further investigation and consideration of differential diagnoses. There is no specific treatment for YNS; therefore, patients must be aware of any intervention's potential harms and limited success.</p>
      </sec>
      <sec id="article-24567.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind about&#x000a0;YNS are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>The diagnosis of YNS requires&#x000a0;2 of the following: yellow nails, lymphedema, and pulmonary disease.</p>
          </list-item>
          <list-item>
            <p>YNS is often misdiagnosed as onychomycosis; however, histopathological analysis of&#x000a0;nail samples&#x000a0;is negative for fungus. Similarly, examination under Wood lamp is typically negative.</p>
          </list-item>
          <list-item>
            <p>YNS can mimic heart failure, a far more common condition, as it also can present with dyspnea on exertion, pleural effusion, and lower extremity edema.</p>
          </list-item>
          <list-item>
            <p>Treatment for YNS is generally supportive and focused on treating symptoms. Symptoms often improve regardless of intervention but usually recur.</p>
          </list-item>
          <list-item>
            <p>Lymphoscintigraphy is a method used to assess&#x000a0;lymphatic&#x000a0;function. Testing is typically abnormal in patients with YNS but is less severe than those with primary lymphedema.</p>
          </list-item>
          <list-item>
            <p>The exact mechanism of YNS is unknown, but it is thought to be due to functional impairment in the lymphatic system that leads to changes in capillary permeability.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24567.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>YNS frequently goes undiagnosed or misdiagnosed for many years. Patients with this condition may exhibit nonspecific signs and symptoms, including cough, recurrent infection, lower extremity edema, and nail discoloration, present in conditions far more&#x000a0;prevalent than YNS, such as heart failure, venous insufficiency, infection, or medication-adverse events. This can lead to patients being referred to many&#x000a0;specialists&#x000a0;in cardiology, infectious disease, endocrinology, and pulmonology.&#x000a0;Although a more common illness is more likely in&#x000a0;patients who present with 2 or 3 signs and symptoms of the triad of YNS, health professionals must communicate effectively and&#x000a0;rule out these other illnesses to limit unnecessary testing, treatment, and consultation. Healthcare professionals must keep YNS on the differential as it is a clinical diagnosis. Approximately&#x000a0;one-third of patients with&#x000a0;YNS have all&#x000a0;3 signs&#x000a0;or symptoms simultaneously.<xref ref-type="bibr" rid="article-24567.r6">[6]</xref>&#x000a0;Furthermore,&#x000a0;a single&#x000a0;symptom may be present for several months or even years, making diagnosis difficult and delayed.<xref ref-type="bibr" rid="article-24567.r46">[46]</xref>&#x000a0;Detailed&#x000a0;documentation of signs&#x000a0;or symptoms and resistance to anchoring bias is essential to prompt diagnosis of YNS.</p>
      </sec>
      <sec id="article-24567.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24567&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24567">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/yellow-nail-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24567">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24567/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24567">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24567.s17">
        <title>References</title>
        <ref id="article-24567.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pavlidakey</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Blum</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1984</year>
            <month>Sep</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>509</fpage>
            <page-range>509-12</page-range>
            <pub-id pub-id-type="pmid">6384296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vignes</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baran</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome: a review.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2017</year>
            <month>Feb</month>
            <day>27</day>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>42</fpage>
            <pub-id pub-id-type="pmid">28241848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>SAMMAN</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>WHITE</surname>
                <given-names>WF</given-names>
              </name>
            </person-group>
            <article-title>THE "YELLOW NAIL" SYNDROME.</article-title>
            <source>Br J Dermatol</source>
            <year>1964</year>
            <month>Apr</month>
            <volume>76</volume>
            <fpage>153</fpage>
            <page-range>153-7</page-range>
            <pub-id pub-id-type="pmid">14140738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Emerson</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Yellow nails, lymphoedema, and pleural effusions.</article-title>
            <source>Thorax</source>
            <year>1966</year>
            <month>May</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>247</fpage>
            <page-range>247-53</page-range>
            <pub-id pub-id-type="pmid">5914998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nordkild</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kromann-Andersen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Struve-Christensen</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome--the triad of yellow nails, lymphedema and pleural effusions. A review of the literature and a case report.</article-title>
            <source>Acta Med Scand</source>
            <year>1986</year>
            <volume>219</volume>
            <issue>2</issue>
            <fpage>221</fpage>
            <page-range>221-7</page-range>
            <pub-id pub-id-type="pmid">3962735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Preston</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Altman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome.</article-title>
            <source>Proc (Bayl Univ Med Cent)</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>526</fpage>
            <page-range>526-527</page-range>
            <pub-id pub-id-type="pmid">30949001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maldonado</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tazelaar</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome: analysis of 41 consecutive patients.</article-title>
            <source>Chest</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>134</volume>
            <issue>2</issue>
            <fpage>375</fpage>
            <page-range>375-381</page-range>
            <pub-id pub-id-type="pmid">18403655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baran</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Pigmentations of the nails (chromonychia).</article-title>
            <source>J Dermatol Surg Oncol</source>
            <year>1978</year>
            <month>Mar</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>250</fpage>
            <page-range>250-4</page-range>
            <pub-id pub-id-type="pmid">632390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stosiek</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Hiller</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Riedl</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hornstein</surname>
                <given-names>OP</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome in a patient with mycosis fungoides.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1993</year>
            <month>May</month>
            <volume>28</volume>
            <issue>5 Pt 1</issue>
            <fpage>792</fpage>
            <page-range>792-4</page-range>
            <pub-id pub-id-type="pmid">8496432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vald&#x000e9;s</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Huggins</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Gude</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ferreiro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Alvarez-Doba&#x000f1;o</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Golpe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Toubes</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Barcala</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Jos&#x000e9;</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Sahn</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of patients with yellow nail syndrome and pleural effusion.</article-title>
            <source>Respirology</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>19</volume>
            <issue>7</issue>
            <fpage>985</fpage>
            <page-range>985-92</page-range>
            <pub-id pub-id-type="pmid">25123563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woodfield</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nisbet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jacob</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mok</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Loebinger</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Hansell</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>AU</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Bronchiectasis in yellow nail syndrome.</article-title>
            <source>Respirology</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>101</fpage>
            <page-range>101-107</page-range>
            <pub-id pub-id-type="pmid">27551950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piraccini</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Urciuoli</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Starace</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tosti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Balestri</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome: clinical experience in a series of 21 patients.</article-title>
            <source>J Dtsch Dermatol Ges</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>131</fpage>
            <page-range>131-7</page-range>
            <pub-id pub-id-type="pmid">24134631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bull</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Fenton</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Mortimer</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Lymphatic function in the yellow nail syndrome.</article-title>
            <source>Br J Dermatol</source>
            <year>1996</year>
            <month>Feb</month>
            <volume>134</volume>
            <issue>2</issue>
            <fpage>307</fpage>
            <page-range>307-12</page-range>
            <pub-id pub-id-type="pmid">8746347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kay&#x00131;ran</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>De La Cruz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tane</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Soran</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Lymphedema: From diagnosis to treatment.</article-title>
            <source>Turk J Surg</source>
            <year>2017</year>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>51</fpage>
            <page-range>51-57</page-range>
            <pub-id pub-id-type="pmid">28740950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Management of pleural effusion, empyema, and lung abscess.</article-title>
            <source>Semin Intervent Radiol</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-86</page-range>
            <pub-id pub-id-type="pmid">22379278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maldonado</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>371</fpage>
            <page-range>371-5</page-range>
            <pub-id pub-id-type="pmid">19373089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Decker</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Daly</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Scher</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Role of Titanium in the Development of Yellow Nail Syndrome.</article-title>
            <source>Skin Appendage Disord</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>28</fpage>
            <page-range>28-30</page-range>
            <pub-id pub-id-type="pmid">27172293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Itagaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Katuhiko</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome following multiple orthopedic surgeries: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2019</year>
            <month>Jul</month>
            <day>01</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>200</fpage>
            <pub-id pub-id-type="pmid">31256758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berglund</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Carlmark</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Titanium, sinusitis, and the yellow nail syndrome.</article-title>
            <source>Biol Trace Elem Res</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>143</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">20809268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarmast</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takriti</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome resulting from cardiac mitral valve replacement.</article-title>
            <source>J Cardiothorac Surg</source>
            <year>2019</year>
            <month>Apr</month>
            <day>11</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>72</fpage>
            <pub-id pub-id-type="pmid">30971303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wells</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome: with familiar primary hypoplasia of lymphatics, manifest late in life.</article-title>
            <source>Proc R Soc Med</source>
            <year>1966</year>
            <month>May</month>
            <volume>59</volume>
            <issue>5</issue>
            <fpage>447</fpage>
            <pub-id pub-id-type="pmid">5933133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Sidhu</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome and bronchial carcinoma.</article-title>
            <source>Chest</source>
            <year>1987</year>
            <month>Jul</month>
            <volume>92</volume>
            <issue>1</issue>
            <fpage>191</fpage>
            <pub-id pub-id-type="pmid">3595241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Samra</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yel</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>T and B cell deficiency associated with yellow nail syndrome.</article-title>
            <source>Scand J Immunol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>75</volume>
            <issue>3</issue>
            <fpage>329</fpage>
            <page-range>329-35</page-range>
            <pub-id pub-id-type="pmid">21995335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siegelman</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Heckman</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Hasson</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Lymphedema, pleural effusions and yellow nails: associated immunologic deficiency.</article-title>
            <source>Dis Chest</source>
            <year>1969</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>2</issue>
            <fpage>114</fpage>
            <page-range>114-7</page-range>
            <pub-id pub-id-type="pmid">5822545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yal&#x000e7;in</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Do&#x0011f;ru</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>G&#x000f6;n&#x000e7;</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Cetinkaya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kiper</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome in an infant presenting with lymphedema of the eyelids and pleural effusion.</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>2004</year>
            <season>Jul-Aug</season>
            <volume>43</volume>
            <issue>6</issue>
            <fpage>569</fpage>
            <page-range>569-72</page-range>
            <pub-id pub-id-type="pmid">15248011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cebeci</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Celebi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Onsun</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Nonclassical yellow nail syndrome in six-year-old girl: a case report.</article-title>
            <source>Cases J</source>
            <year>2009</year>
            <month>Oct</month>
            <day>24</day>
            <volume>2</volume>
            <fpage>165</fpage>
            <pub-id pub-id-type="pmid">19946476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jayaraj</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Raju</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pace</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>The diagnostic unreliability of classic physical signs of lymphedema.</article-title>
            <source>J Vasc Surg Venous Lymphat Disord</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>890</fpage>
            <page-range>890-897</page-range>
            <pub-id pub-id-type="pmid">31281100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>King</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of lymphoedema.</article-title>
            <source>Nurs Times</source>
            <string-date>2006 Mar 28-Apr 3</string-date>
            <volume>102</volume>
            <issue>13</issue>
            <fpage>47</fpage>
            <page-range>47, 49, 51</page-range>
            <pub-id pub-id-type="pmid">16605153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Novis</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Akkina</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Lynn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kern</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Keshavarzi</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Pynnonen</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>A diagnostic dilemma: chronic sinusitis diagnosed by non-otolaryngologists.</article-title>
            <source>Int Forum Allergy Rhinol</source>
            <year>2016</year>
            <month>May</month>
            <volume>6</volume>
            <issue>5</issue>
            <fpage>486</fpage>
            <page-range>486-90</page-range>
            <pub-id pub-id-type="pmid">26750399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iqbal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rossoff</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Marzouk</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Steinberg</surname>
                <given-names>HN</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome: resolution of yellow nails after successful treatment of breast cancer.</article-title>
            <source>Chest</source>
            <year>2000</year>
            <month>May</month>
            <volume>117</volume>
            <issue>5</issue>
            <fpage>1516</fpage>
            <page-range>1516-8</page-range>
            <pub-id pub-id-type="pmid">10807848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brooks</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Echevarria</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bourke</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Case-based discussion from North Tyneside General Hospital: somatostatin analogues in yellow nail syndrome associated with recurrent pleural effusions.</article-title>
            <source>Thorax</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>69</volume>
            <issue>10</issue>
            <fpage>967</fpage>
            <page-range>967-8</page-range>
            <pub-id pub-id-type="pmid">24923874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Norton</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Further observations on the yellow nail syndrome with therapeutic effects of oral alpha-tocopherol.</article-title>
            <source>Cutis</source>
            <year>1985</year>
            <month>Dec</month>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>457</fpage>
            <page-range>457-62</page-range>
            <pub-id pub-id-type="pmid">4075838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tosti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Piraccini</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Iorizzo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Systemic itraconazole in the yellow nail syndrome.</article-title>
            <source>Br J Dermatol</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>146</volume>
            <issue>6</issue>
            <fpage>1064</fpage>
            <page-range>1064-7</page-range>
            <pub-id pub-id-type="pmid">12072079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Samman</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Yellow nail syndrome treated by intralesional triamcinolone acetonide.</article-title>
            <source>Br J Dermatol</source>
            <year>1973</year>
            <month>Feb</month>
            <volume>88</volume>
            <issue>2</issue>
            <fpage>200</fpage>
            <page-range>200-1</page-range>
            <pub-id pub-id-type="pmid">4706464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arroyo</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Improvement of yellow nail syndrome with oral zinc supplementation.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>1993</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-4</page-range>
            <pub-id pub-id-type="pmid">8440057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suzuki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yoshizawa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sugiyama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ichimura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Morita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Takasaki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Naka</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hirano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Izumi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hoji</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kudo</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>A case of yellow nail syndrome with dramatically improved nail discoloration by oral clarithromycin.</article-title>
            <source>Case Rep Dermatol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>251</fpage>
            <page-range>251-8</page-range>
            <pub-id pub-id-type="pmid">22220146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <collab>International Society of Lymphology</collab>
            <article-title>The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology.</article-title>
            <source>Lymphology</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>46</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-11</page-range>
            <pub-id pub-id-type="pmid">23930436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dallmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Attanoos</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Yellow Nail Syndrome with Bilateral Pleural Plaques and Diffuse Pleural Thickening: A Mimic of Asbestos Related Disease.</article-title>
            <source>Case Rep Pulmonol</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>7302898</fpage>
            <pub-id pub-id-type="pmid">30345138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porcel</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Pleural effusions from congestive heart failure.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>689</fpage>
            <page-range>689-97</page-range>
            <pub-id pub-id-type="pmid">21213200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaur</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kashyap</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bhalla</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Onychomycosis--epidemiology, diagnosis and management.</article-title>
            <source>Indian J Med Microbiol</source>
            <year>2008</year>
            <season>Apr-Jun</season>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>108</fpage>
            <page-range>108-16</page-range>
            <pub-id pub-id-type="pmid">18445944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daniels</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Improving the safety of thoracentesis.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>232</fpage>
            <page-range>232-6</page-range>
            <pub-id pub-id-type="pmid">21346571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eid</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Keddissi</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Kinasewitz</surname>
                <given-names>GT</given-names>
              </name>
            </person-group>
            <article-title>Hypoalbuminemia as a cause of pleural effusions.</article-title>
            <source>Chest</source>
            <year>1999</year>
            <month>Apr</month>
            <volume>115</volume>
            <issue>4</issue>
            <fpage>1066</fpage>
            <page-range>1066-9</page-range>
            <pub-id pub-id-type="pmid">10208209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okajima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hirota</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Inagaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tamai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Iizaka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakagami</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sugama</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sanada</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Health-related quality of life and associated factors in patients with primary lymphedema.</article-title>
            <source>Jpn J Nurs Sci</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>202</fpage>
            <page-range>202-11</page-range>
            <pub-id pub-id-type="pmid">24373443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mortimer</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Swollen lower limb-2: lymphoedema.</article-title>
            <source>BMJ</source>
            <year>2000</year>
            <month>Jun</month>
            <day>03</day>
            <volume>320</volume>
            <issue>7248</issue>
            <fpage>1527</fpage>
            <page-range>1527-9</page-range>
            <pub-id pub-id-type="pmid">10834903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ayata</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Unal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ersanli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bilge</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Ocular findings in yellow nail syndrome.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>493</fpage>
            <page-range>493-4</page-range>
            <pub-id pub-id-type="pmid">18711477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24567.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bauer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>KF</given-names>
              </name>
            </person-group>
            <article-title>"You have a syndrome"-words you don't want to hear from a doctor. Battling yellow nail syndrome.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>11</volume>
            <issue>9</issue>
            <fpage>1476</fpage>
            <page-range>1476-9</page-range>
            <pub-id pub-id-type="pmid">25422998</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
